S. Koochekpour, Androgen receptor signaling and mutations in prostate cancer, Asian Journal of Andrology, vol.12, issue.5, pp.639-57, 2010.
DOI : 10.1038/aja.2010.89

T. Visakorpi, E. Hyytinen, P. Koivisto, M. Tanner, and R. Keinanen, In vivo amplification of the androgen receptor gene and progression of human prostate cancer, Nature Genetics, vol.8, issue.4, pp.401-407, 1995.
DOI : 10.1016/0046-8177(92)90083-F

R. Sramkoski, T. Pretlow, J. Giaconia, T. Pretlow, and S. Schwartz, A new human prostate carcinoma cell line, 22Rv1, In Vitro Cellular & Developmental Biology - Animal, vol.54, issue.7, pp.403-412, 1999.
DOI : 10.1093/ajcp/106.5.647

B. Comuzzi and M. Sadar, Proteomic analyses to identify novel therapeutic targets for the treatment of advanced prostate cancer, Cellscience, vol.3, pp.61-81, 2006.

E. Gasteiger, A. Gattiker, C. Hoogland, I. Ivanyi, and R. Appel, ExPASy: the proteomics server for in-depth protein knowledge and analysis, Nucleic Acids Research, vol.31, issue.13, pp.3784-3792, 2003.
DOI : 10.1093/nar/gkg563

S. Lefever, J. Vandesompele, F. Speleman, and F. Pattyn, RTPrimerDB: the portal for real-time PCR primers and probes, Nucleic Acids Research, vol.37, issue.Database, pp.942-947, 2009.
DOI : 10.1093/nar/gkn777
URL : http://doi.org/10.1093/nar/gkn777

C. Huggins and C. Hodges, Studies on Prostatic Cancer: I. The Effect of Castration, Of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate, CA: A Cancer Journal for Clinicians, vol.22, issue.4, pp.293-300, 1941.
DOI : 10.3322/canjclin.22.4.232

Y. Li, T. Hwang, L. Oseth, A. Hauge, and R. Vessella, AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression, Oncogene, vol.61, issue.45, pp.4759-67, 2012.
DOI : 10.1158/1078-0432.CCR-08-0979

I. Leav, K. Lau, J. Adams, J. Mcneal, and M. Taplin, Comparative Studies of the Estrogen Receptors ? and ? and the Androgen Receptor in Normal Human Prostate Glands, Dysplasia, and in Primary and Metastatic Carcinoma, The American Journal of Pathology, vol.159, issue.1, pp.79-92, 2001.
DOI : 10.1016/S0002-9440(10)61676-8

L. Menasce, G. White, C. Harrison, and J. Boyle, Localization of the Estrogen Receptor Locus (ESR) to Chromosome 6q25.1 by FISH and a Simple Post-FISH Banding Technique, Genomics, vol.17, issue.1, pp.263-268, 1993.
DOI : 10.1006/geno.1993.1320

W. Wu, G. Wang, S. Baek, and R. Shen, Comparative Study of Three Proteomic Quantitative Methods, DIGE, cICAT, and iTRAQ, Using 2D Gel- or LC?MALDI TOF/TOF, Journal of Proteome Research, vol.5, issue.3, pp.651-659, 2006.
DOI : 10.1021/pr050405o

B. Cipolla, J. Ziade, J. Bansard, J. Moulinoux, and F. Staerman, Pretherapeutic erythrocyte polyamine spermine levels discriminate high risk relapsing patients with M1 prostate carcinoma, Cancer, vol.43, issue.5, pp.1055-65, 1996.
DOI : 10.1016/S0140-6736(95)92163-X

A. Mccann and P. , Polyamine metabolism and function, Am J Physiol, vol.243, pp.212-233, 1982.

S. Mumenthaler, H. Yu, S. Tze, S. Cederbaum, and A. Pegg, Expression of arginase II in prostate cancer, International Journal of Oncology, vol.32, pp.357-65, 2008.
DOI : 10.3892/ijo.32.2.357

M. Mueckler, S. Moran, and H. Pitot, Transcriptional control of ornithine aminotransferase synthesis in rat kidney by estrogen and thyroid hormone, J Biol Chem, vol.259, pp.2302-2307, 1984.

H. Konishi, H. Matsuzaki, M. Tanaka, Y. Takemura, and S. Kuroda, Activation of protein kinase B (Akt/RAC-protein kinase) by cellular stress and its association with heat shock protein Hsp27, FEBS Letters, vol.15, issue.2-3, pp.493-501, 1997.
DOI : 10.1016/0092-8674(94)90278-X

C. Garrido, J. Bruey, A. Fromentin, A. Hammann, and A. Arrigo, HSP27 inhibits cytochrome c-dependent activation of procaspase-9, Faseb J, vol.13, pp.2061-70, 1999.

J. Bruey, C. Ducasse, P. Bonniaud, L. Ravagnan, and S. Susin, Hsp27 negatively regulates cell death by interacting with cytochrome c, Nat Cell Biol, vol.2, pp.645-52, 2000.

D. Adams, D. Edwards, and W. Mcguire, Estrogen regulation of specific proteins as a mode of hormone action in human breast cancer, Biomembranes, vol.11, pp.389-414, 1983.

C. Foster, A. Dodson, L. Ambroisine, G. Fisher, and H. Moller, Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement, British Journal of Cancer, vol.20, issue.7, pp.1137-1181, 2009.
DOI : 10.1158/0008-5472.CAN-07-2057

A. 33-glaessgen, S. Jonmarker, A. Lindberg, B. Nilsson, and R. Lewensohn, Heat shock proteins 27, 60 and 70 as prognostic markers of prostate cancer?, APMIS, vol.280, issue.10, pp.888-95, 2008.
DOI : 10.1128/MCB.7.8.2863

H. Miyake, M. Muramaki, T. Kurahashi, A. Takenaka, and M. Fujisawa, Expression of potential molecular markers in prostate cancer: Correlation with clinicopathological outcomes in patients undergoing radical prostatectomy, Urologic Oncology: Seminars and Original Investigations, vol.28, issue.2, pp.145-51, 2010.
DOI : 10.1016/j.urolonc.2008.08.001

G. Grotendorst, L. Lau, and B. Perbal, CCN Proteins Are Distinct from and Should Not Be Considered Members of the Insulin-Like Growth Factor-Binding Protein Superfamily, Endocrinology, vol.141, issue.6, pp.2254-2260, 2000.
DOI : 10.1210/endo.141.6.7485

P. Jenkins and S. Bustin, Evidence for a link between IGF-I and cancer, European Journal of Endocrinology, vol.151, issue.Suppl_1, pp.17-22, 2004.
DOI : 10.1530/eje.0.151S017
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.573.6858

A. Roddam, N. Allen, P. Appleby, T. Key, and L. Ferrucci, Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies, Ann Intern Med, vol.149, pp.461-71, 2008.

D. Degraff, M. Malik, Q. Chen, K. Miyako, and L. Rejto, Hormonal regulation of IGFBP-2 proteolysis is attenuated with progression to androgen insensitivity in the LNCaP progression model, Journal of Cellular Physiology, vol.12, issue.1, pp.261-269, 2007.
DOI : 10.1002/jcp.21123

C. Uzoh, J. Holly, K. Biernacka, R. Persad, and A. Bahl, Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel, British Journal of Cancer, vol.70, issue.10, pp.1587-93
DOI : 10.1111/j.1464-410X.2009.08411.x

R. Geier, S. Adler, G. Rashid, and A. Klein, The synthetic estrogen diethylstilbestrol (DES) inhibits the telomerase activity and gene expression of prostate cancer cells, The Prostate, vol.53, pp.1307-1319, 2010.
DOI : 10.1172/JCI0215552

E. Cavalieri, K. Frenkel, J. Liehr, E. Rogan, and D. Roy, Chapter 4: Estrogens as Endogenous Genotoxic Agents--DNA Adducts and Mutations, JNCI Monographs, vol.2000, issue.27, pp.75-93, 2000.
DOI : 10.1093/oxfordjournals.jncimonographs.a024247
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.548.8702